The week at Retraction Watch featured a lawsuit threat following criticism of a popular education program, and the new editor of PLOS ONE’s explanation of why submissions are down. Here’s what was happening elsewhere:
John Antonakis is psychologist by training, but his research has run the gamut from showing kids accurately predict election outcomes just by looking at candidates’ faces to teaching charisma to people in leadership positions. Now, as the newly appointed editor of The Leadership Quarterly, he’s tackling problems in academic publishing. But his approach is somewhat … Continue reading Got “significosis?” Here are the five diseases of academic publishing
Researchers in China have retracted two 2016 papers about the possible use of a cholesterol-lowering agent to treat bleeding on the brain. One of the retracted papers in the Journal of Neurosurgery (JNS) had multiple problems that were “too extensive to revise,” according to the lengthy retraction notice, relating to issues with authorship, data analyses, … Continue reading Authors retract two statin papers, one with problems “too extensive to revise”
In 2012, John Carlisle, a British anesthesiologist, demonstrated conclusively using statistics that Yoshitaka Fujii had faked data in many studies. Fujii — as followers of this blog well know — now holds the record for most retractions by an individual author (183). Carlisle’s work accomplished two things: It put to rest any doubt that problems … Continue reading Co-author of retraction record-holder likely fabricated his own data, analysis shows
The week at Retraction Watch featured the retraction of a physics society’s press release quoting U.S. president-elect Donald Trump, and an apparent blow for clairvoyance research. Here’s what was happening elsewhere:
A new analysis of more than 30 clinical trials co-authored by a bone researcher based in Japan is casting doubt on the legitimacy of the findings. Yoshihiro Sato, based at Mitate Hospital, has already retracted 12 papers, for reasons ranging from data problems, to including co-authors without their consent, to self-plagiarism. Most of these retracted papers are … Continue reading Analysis casts doubt on bone researcher’s body of work
A second paper about a major randomized trial in Japanese patients with heart disease is being retracted, after an investigation reportedly found multiple problems with the paper. As predicted by Pharma Japan, Hypertension Research is retracting a 2011 paper, already the subject of two errata. Although a spokesperson said she couldn’t say why the paper was being retracted, as … Continue reading Second paper about major blood pressure drug trial in Japan to be retracted
Although previous research has suggested peer reviewers are not influenced by knowing the authors’ identity and affiliation, a new Research Letter published today in JAMA suggests otherwise. In “Single-blind vs Double-blind Peer Review in the Setting of Author Prestige,” Kanu Okike at Kaiser Moanalua Medical Center in Hawaii and his colleagues created a fake manuscript … Continue reading Reviewers may rate papers differently when blinded to authors’ identities, new study says
Authors of a 2016 cancer paper have retracted it after finding an error in one line of code in the program used to calculate some of the results. Sarah Darby, last author of the now-retracted paper from the University of Oxford, UK, told Retraction Watch that the mistake was made by a doctoral student. When … Continue reading Error in one line of code sinks cancer study
An electroconvulsive therapy (ECT) journal has retracted two 2016 papers after uncovering problems in the data analyses, which the author says were due to language barriers. Interestingly, two authors of the newly retracted papers — Yu-Tao Xiang from the University of Macau in China and Gabor Ungvari from the University of Western Australia — also … Continue reading Authors retract two papers on shock therapy, citing language barriers